Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose versus conventional-dose bupivacaine for spinal anesthesia in severe preeclampsia
IRCT2016091714056N9Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of bupivacaine in preeclampsia (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Blood pressure changes. Started May 2016; status: completed.
02
Drugs
bupivacaine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT2016091714056N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016091714056N9.